DOCSLIB.ORG

Subject: ACCEPTED FORM TYPE 10-K (0001193125-12-076983) Date: 24-Feb-2012 09:29

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Subject: ACCEPTED FORM TYPE 10-K (0001193125-12-076983) Date: 24-Feb-2012 09:29 Subject: ACCEPTED FORM TYPE 10-K (0001193125-12-076983) Date: 24-Feb-2012 09:29 THE FOLLOWING SUBMISSION HAS BEEN ACCEPTED BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. COMPANY: Philip Morris International Inc. FORM TYPE: 10-K NUMBER OF DOCUMENTS: 17 RECEIVED DATE: 24-Feb-2012 09:28 ACCEPTED DATE: 24-Feb-2012 09:29 FILING DATE: 24-Feb-2012 09:28 TEST FILING: NO CONFIRMING COPY: NO ACCESSION NUMBER: 0001193125-12-076983 FILE NUMBER(S): 1. 001-33708 THE PASSWORD FOR LOGIN CIK 0001193125 WILL EXPIRE 09-Feb-2013 13:14. PLEASE REFER TO THE ACCESSION NUMBER LISTED ABOVE FOR FUTURE INQUIRIES. REGISTRANT(S): 1. CIK: 0001413329 COMPANY: Philip Morris International Inc. ACCELERATED FILER STATUS: LARGE ACCELERATED FILER FORM TYPE: 10-K FILE NUMBER(S): 1. 001-33708 24-Feb-2012 09:29 Page 1 of 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ⌧ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33708 PHILIP MORRIS INTERNATIONAL INC. (Exact name of registrant as specified in its charter) Virginia 13-3435103 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 120 Park Avenue, New York, New York 10017 (Address of principal executive offices) (Zip Code) 917-663-2000 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Common Stock, no par value New York Stock Exchange 4.875% Notes due 2013 New York Stock Exchange 6.875% Notes due 2014 New York Stock Exchange 5.875% Notes due 2015 New York Stock Exchange 2.500% Notes due 2016 New York Stock Exchange 5.650% Notes due 2018 New York Stock Exchange 4.500% Notes due 2020 New York Stock Exchange 4.125% Notes due 2021 New York Stock Exchange 2.900% Notes due 2021 New York Stock Exchange 6.375% Notes due 2038 New York Stock Exchange 4.375% Notes due 2041 New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T; during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. Large accelerated filer Accelerated filer Non-accelerated filer Smaller reporting company (Do not check if a smaller reporting company) Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No As of June 30, 2011, the aggregate market value of the registrant’s common stock held by non-affiliates of the registrant was approximately $118 billion based on the closing sale price of the common stock as reported on the New York Stock Exchange. Class Outstanding at January 31, 2012 Common Stock, 1,721,873,303 shares no par value DOCUMENTS INCORPORATED BY REFERENCE Document Parts Into Which Incorporated Portions of the registrant’s annual report to shareholders for the year ended Parts I, II, and IV December 31, 2011 (the “2011 Annual Report”) Portions of the registrant’s definitive proxy statement for use in connection with its Part III annual meeting of shareholders to be held on May 9, 2012, to be filed with the Securities and Exchange Commission (“SEC”) on or about March 30, 2012 TABLE OF CONTENTS Page PART I Item 1. Business 1 Item 1A. Risk Factors 9 Item 1B. Unresolved Staff Comments 14 Item 2. Properties 14 Item 3. Legal Proceedings 14 Item 4. Mine Safety Disclosures 25 PART II Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 26 Item 6. Selected Financial Data 27 Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 27 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 27 Item 8. Financial Statements and Supplementary Data 27 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 27 Item 9A. Controls and Procedures 27 Item 9B. Other Information 27 PART III Item 10. Directors, Executive Officers and Corporate Governance 28 Item 11. Executive Compensation 29 Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 29 Item 13. Certain Relationships and Related Transactions, and Director Independence 29 Item 14. Principal Accounting Fees and Services 29 PART IV Item 15. Exhibits and Financial Statement Schedules 30 Signatures 36 In this report, “PMI,” “we,” “us” and “our” refers to Philip Morris International Inc. and subsidiaries. PART I Item 1. Business. (a) General Development of Business General Philip Morris International Inc. is a Virginia holding company incorporated in 1987. Our subsidiaries and affiliates and their licensees are engaged in the manufacture and sale of cigarettes and other tobacco products in markets outside of the United States of America. Our products are sold in approximately 180 countries and, in many of these countries, they hold the number one or number two market share position. We have a wide range of premium, mid-price and low-price brands. Our portfolio comprises both international and local brands. Our portfolio of international and local brands is led by Marlboro, the world’s best selling international cigarette, which accounted for approximately 33% of our total 2011 shipment volume. Marlboro is complemented in the premium- price category by Merit, Parliament and Virginia Slims. Our leading mid-price brands are L&M and Chesterfield. Other leading international brands include Bond Street, Lark, Muratti, Next, Philip Morris and Red & White. We also own a number of important local cigarette brands, such as Sampoerna A, Dji Sam Soe and Sampoerna Kretek in Indonesia, Fortune, Champion and Hope in the Philippines, Diana in Italy, Optima and Apollo-Soyuz in Russia, Morven Gold in Pakistan, Boston in Colombia, Belmont, Canadian Classics and Number 7 in Canada, Best and Classic in Serbia, f6 in Germany, Delicados in Mexico, Assos in Greece and Petra in the Czech Republic and Slovakia. While there are a number of markets where local brands remain important, international brands are expanding their share in numerous markets. With international brands contributing approximately 70% of our shipment volume in 2011, we are well-positioned to continue to benefit from this trend. Separation from Altria Group, Inc. We were a wholly owned subsidiary of Altria Group, Inc. (“Altria”) until the distribution of all of our shares owned by Altria (the “Spin-off”) was made on March 28, 2008 (the “Distribution Date”). Acquisitions and Other Business Arrangements During 2011, 2010 and 2009, we expanded our business with the following transactions: 2011: In June 2011, we completed the acquisition of a cigarette business in Jordan, consisting primarily of cigarette manufacturing assets and inventories, for $42 million. In January 2011, we acquired a cigar business, consisting primarily of trademarks in the Australian and New Zealand markets, for $20 million. Effective January 1, 2011, we established a new business structure with Vietnam National Tobacco Corporation (“Vinataba”) in Vietnam, further developing our existing joint venture with Vinataba through the licensing of Marlboro and establishing a PMI-controlled branch for the building of our brands. -1- 2010: In February 2010, our affiliate, Philip Morris Philippines Manufacturing Inc. (“PMPMI”), and Fortune Tobacco Corporation (“FTC”) combined their respective business activities by transferring selected assets and liabilities of PMPMI and FTC to a new company called PMFTC Inc. (“PMFTC”). PMPMI and FTC hold equal economic interests in PMFTC, while we manage the day-to-day operations of PMFTC and have a majority of its Board of Directors. The establishment of PMFTC permits both parties to benefit from their complementary brand portfolios, as well as cost synergies from the resulting integration of manufacturing, distribution and procurement, and the further development and advancement of tobacco growing in the Philippines. In June 2010, we announced that our affiliate, Philip Morris Brasil Industria e Comercio Ltda. (“PMB”), would begin directly sourcing tobacco leaf from approximately 17,000 tobacco farmers in Southern Brazil.
Load more

Recommended publications
  • I UNITED STATES DISTRICT COURT for the DISTRICT OF
    Case 1:99-cv-02496-PLF Document 6276 Filed 08/03/18 Page 1 of 59 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA ____________________________________ UNITED STATES OF AMERICA, ) Plaintiff, ) Civil Action No. 99-CV-2496 (PLF) ) and ) ) CAMPAIGN FOR TOBACCO-FREE ) KIDS, et al., ) Plaintiff-Intervenors, ) ) v. ) ) PHILIP MORRIS USA INC., et al., ) Defendants. ) ) and ) ) ITG BRANDS, LLC, et al., ) Post-Judgment Parties ) Regarding Remedies ) PLAINTIFFS’ 2018 SUPPLEMENTAL BRIEF ON RETAIL POINT OF SALE REMEDY TABLE OF CONTENTS TABLE OF AUTHORITIES ......................................................................................................... iv INTRODUCTION .......................................................................................................................... 1 FACTUAL BACKGROUND ......................................................................................................... 5 I. The Deal between Cigarette Manufacturers and Retailers ............................................... 5 II. Benefits to Participating Retailers .................................................................................... 6 III. Manufacturers’ Contractual Control over Space for Cigarette Marketing and Promotional Displays ....................................................................................................... 8 A. The types of retail advertising and marketing space ........................................8 B. The manufacturers’ contractual authority over participating retailers’ space 10 1. The
    [Show full text]
  • PM 12.31.2014 Form 10K Wrap (Incl F/S & MD&A)
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33708 PHILIP MORRIS INTERNATIONAL INC. (Exact name of registrant as specified in its charter) Virginia 13-3435103 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 120 Park Avenue, New York, New York 10017 (Address of principal executive offices) (Zip Code) 917-663-2000 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Common Stock, no par value New York Stock Exchange Floating Rate Notes due 2015 New York Stock Exchange 5.875% Notes due 2015 New York Stock Exchange 2.500% Notes due 2016 New York Stock Exchange 1.625% Notes due 2017 New York Stock Exchange 1.125% Notes due 2017 New York Stock Exchange 1.250% Notes due 2017 New York Stock Exchange 5.650% Notes due 2018 New York Stock Exchange 1.875% Notes due 2019 New York Stock Exchange 2.125% Notes due 2019 New York Stock Exchange 1.750% Notes due 2020 New York Stock Exchange 4.500% Notes due 2020 New York Stock Exchange 1.875% Notes due 2021 New York Stock Exchange 4.125% Notes due 2021 New York Stock Exchange 2.900% Notes due 2021 New York Stock Exchange
    [Show full text]
  • Altria Group, Inc. Annual Report
    Altria Group, Inc. 2019 Annual Report an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company Howard A. Willard III Dear Fellow Shareholders Chairman of the Board and CEO Altria delivered solid performance in a dynamic year for the tobacco industry. Our core tobacco businesses delivered outstanding financial performance, and we made significant progress advancing our non-combustible product platform. We believe Altria’s enhanced business platform positions us well for future success. 2019 Highlights n Grew adjusted diluted earnings per share (EPS) by 5.8%, primarily driven by our core tobacco businesses; and types of legal cases pending against it, especially during the fourth n Achieved $600 million in annualized cost savings, exceeding our $575 quarter of the year. Altria recorded two impairment charges of our JUUL million target announced in December 2018; asset in 2019, reducing our investment to $4.2 billion at year-end, down from n Increased our regular quarterly dividend for the 54th time in 50 years $12.8 billion, our 2019 initial investment. JUUL remains the U.S. leader in the and paid shareholders approximately $6.1 billion in dividends; and e-vapor category, and in January 2020 we revised certain terms governing n Repurchased 16.5 million Altria shares for a total cost of $845 million.
    [Show full text]
  • Altria Group, Inc. Annual Report
    ananan Altria Altria Altria Company Company Company an Altria Company ananan Altria Altria Altria Company Company Company | Inc. Altria Group, Report 2020 Annual an Altria Company From tobacco company To tobacco harm reduction company ananan Altria Altria Altria Company Company Company an Altria Company ananan Altria Altria Altria Company Company Company an Altria Company Altria Group, Inc. Altria Group, Inc. | 6601 W. Broad Street | Richmond, VA 23230-1723 | altria.com 2020 Annual Report Altria 2020 Annual Report | Andra Design Studio | Tuesday, February 2, 2021 9:00am Altria 2020 Annual Report | Andra Design Studio | Tuesday, February 2, 2021 9:00am Dear Fellow Shareholders March 11, 2021 Altria delivered outstanding results in 2020 and made steady progress toward our 10-Year Vision (Vision) despite the many challenges we faced. Our tobacco businesses were resilient and our employees rose to the challenge together to navigate the COVID-19 pandemic, political and social unrest, and an uncertain economic outlook. Altria’s full-year adjusted diluted earnings per share (EPS) grew 3.6% driven primarily by strong performance of our tobacco businesses, and we increased our dividend for the 55th time in 51 years. Moving Beyond Smoking: Progress Toward Our 10-Year Vision Building on our long history of industry leadership, our Vision is to responsibly lead the transition of adult smokers to a non-combustible future. Altria is Moving Beyond Smoking and leading the way by taking actions to transition millions to potentially less harmful choices — a substantial opportunity for adult tobacco consumers 21+, Altria’s businesses, and society. To achieve our Vision, we are building a deep understanding of evolving adult tobacco consumer preferences, expanding awareness and availability of our non-combustible portfolio, and, when authorized by FDA, educating adult smokers about the benefits of switching to alternative products.
    [Show full text]
  • Temporary Compliance Waiver Notice the Linked Files May Not Be Fully Accessible to Readers Using Assistive Technology
    Temporary Compliance Waiver Notice The linked files may not be fully accessible to readers using assistive technology. We regret any inconvenience that this may cause our readers. In the event you are unable to read the documents or portions thereof, please email [email protected] or call 1-877-287-1373. Philip Morris Products S.A. THS Page 1 PMI Research & Development 2.7 Executive Summary MRTPA Section 2.7 Executive Summary Confidentiality Statement Confidentiality Statement: Data and information contained in this document are considered to constitute trade secrets and confidential commercial information, and the legal protections provided to such trade secrets and confidential information are hereby claimed under the applicable provisions of United States law. No part of this document may be publicly disclosed without the written consent of Philip Morris International. Philip Morris Products S.A. THS Page 2 PMI Research & Development 2.7 Executive Summary TABLE OF CONTENTS 2.7.1 EXECUTIVE SUMMARY .....................................................................................9 2.7.2 PROPOSED MODIFIED RISK AND MODIFIED EXPOSURE CLAIMS ........15 2.7.3 MODIFIED RISK TOBACCO PRODUCTS AND HARM REDUCTION .........17 2.7.4 PRODUCT DESCRIPTION AND SCIENTIFIC RATIONALE ..........................19 Development Rationale and Product Description for THS ............................................19 Heating Instead of Burning Reduces Harmful Constituents ......................................19 Product Description ...................................................................................................20
    [Show full text]
  • Complete Annual Report
    Philip Morris International 2016 Annual Report THIS CHANGES EVERYTHING 2016 Philip Morris Annual Report_LCC/ANC Review Copy February 22 - Layout 2 We’ve built the world’s most successful cigarette company with the world’s most popular and iconic brands. Now we’ve made a dramatic decision. We’ve started building PMI’s future on breakthrough smoke-free products that are a much better choice than cigarette smoking. We’re investing to make these products the Philip Morris icons of the future. In these changing times, we’ve set a new course for the company. We’re going to lead a full-scale effort to ensure that smoke- free products replace cigarettes to the benefit of adult smokers, society, our company and our shareholders. Reduced-Risk Products - Our Product Platforms Heated Tobacco Products Products Without Tobacco Platform Platform 1 3 IQOS, using the consumables Platform 3 is based on HeatSticks or HEETS, acquired technology that features an electronic holder uses a chemical process to that heats tobacco rather Platform create a nicotine-containing than burning it, thereby 2 vapor. We are exploring two Platform creating a nicotine-containing routes for this platform: one 4 vapor with significantly fewer TEEPS uses a pressed with electronics and one harmful toxicants compared to carbon heat source that, once without. A city launch of the Products under this platform cigarette smoke. ignited, heats the tobacco product is planned in 2017. are e-vapor products – without burning it, to generate battery-powered devices a nicotine-containing vapor that produce an aerosol by with a reduction in harmful vaporizing a nicotine solution.
    [Show full text]
  • Sales -- Implied Warranty -- Cigarette Manufacturer's Liability for Lung Cancer Henry S
    NORTH CAROLINA LAW REVIEW Volume 42 | Number 2 Article 18 2-1-1964 Sales -- Implied Warranty -- Cigarette Manufacturer's Liability for Lung Cancer Henry S. Manning Jr. Follow this and additional works at: http://scholarship.law.unc.edu/nclr Part of the Law Commons Recommended Citation Henry S. Manning Jr., Sales -- Implied Warranty -- Cigarette Manufacturer's Liability for Lung Cancer, 42 N.C. L. Rev. 468 (1964). Available at: http://scholarship.law.unc.edu/nclr/vol42/iss2/18 This Note is brought to you for free and open access by Carolina Law Scholarship Repository. It has been accepted for inclusion in North Carolina Law Review by an authorized editor of Carolina Law Scholarship Repository. For more information, please contact [email protected]. NORTH CAROLINA LAW REVIEW [Vol. 42 lingering, ominous cloud of illegality under the Robinson-Patman Act. JAMES M. TALLEY, JR. Sales-Implied Warranty-Cigarette Manufacturer's Liability for Lung Cancer Plaintiff's decedent initiated suit in the United States District Court for the Southern District of Florida to recover damages for personal injuries resulting from lung cancer allegedly incurred by smoking Lucky Strike cigarettes. Shortly thereafter, he died from this condition and this claim1 was consolidated with another brought under the Florida wrongful death statute.' The district court sub- mitted the case to the jury on theories of negligence and breach of implied warranty.' In addition to rendering a general verdict for defendant, the jury answered specific interrogatories4 to the effect that the fatal lung cancer was proximately caused by the smoking of Lucky Strikes and that, as of the time of the discovery of the cancer, defendant could not by the reasonable application of human skill and foresight have known of the danger to users of his product.
    [Show full text]
  • EU Tobacco Products Directive 2014/40/EC
    29.4.2014 EN Official Journal of the European Union L 127/1 I (Legislative acts) DIRECTIVES DIRECTIVE 2014/40/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 3 April 2014 on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products and repealing Directive 2001/37/EC (Text with EEA relevance) THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION, Having regard to the Treaty on the Functioning of the European Union, and in particular Articles 53(1), 62 and 114 thereof, Having regard to the proposal from the European Commission, After transmission of the draft legislative act to the national parliaments, Having regard to the opinion of the European Economic and Social Committee ( 1 ), Having regard to the opinion of the Committee of the Regions ( 2), Acting in accordance with the ordinary legislative procedure ( 3 ), Whereas: (1) Directive 2001/37/EC of the European Parliament and of the Council ( 4) lays down rules at Union level concerning tobacco products. In order to reflect scientific, market and international developments, substantial changes to that Directive would be needed and it should therefore be repealed and replaced by a new Directive. (2) In its reports of 2005 and 2007 on the application of Directive 2001/37/EC the Commission identified areas in which further action was considered useful for the smooth functioning of the internal market. In 2008 and 2010 the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) provided scientific advice to the Commission on smokeless tobacco products and tobacco additives.
    [Show full text]
  • Case No COMP/M.3191 - PHILIP MORRIS / PAPASTRATOS
    EN Case No COMP/M.3191 - PHILIP MORRIS / PAPASTRATOS Only the English text is available and authentic. REGULATION (EEC) No 4064/89 MERGER PROCEDURE Article 6(1)(b) NON-OPPOSITION Date: 02/10/2003 Also available in the CELEX database Document No 303M3191 Office for Official Publications of the European Communities L-2985 Luxembourg COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 02/10/2003 SG (2003) D/232408 In the published version of this decision, PUBLIC VERSION some information has been omitted pursuant to Article 17(2) of Council Regulation (EEC) No 4064/89 concerning non-disclosure of MERGER PROCEDURE business secrets and other confidential ARTICLE 6(1)(b) DECISION information. The omissions are shown thus […]. Where possible the information omitted has been replaced by ranges of figures or a To the notifying parties general description. Dear Sir/Madam, Subject: Case No COMP/M.3191 - PHILIP MORRIS/PAPASTRATOS Notification of 2.9.2003 pursuant to Article 4 of Council Regulation No 4064/891 1. On 2.9.2003, Philip Morris Holland BV notified its intention to acquire control of the whole of Papastratos Cigarette Manufacturing SA (“Papastratos”) within the meaning of Art 3(1)b of the Merger Regulation. 2. The Commission has concluded that the notified operation falls within the scope of the Merger Regulation as amended and does not raise serious doubts as to its compatibility with the common market and with the functioning of the EEA Agreement. I. THE PARTIES 3. Philip Morris Holland BV is a subsidiary of Philip Morris International Inc. ("Philip Morris"), an affiliate of Altria Group, Inc.
    [Show full text]
  • PHILIP MORRIS USA PERSONNEL NUMBER ORGANIZATION’S CITY/STATE/ZIP CODE Please Include Any Leading Zeros
    Part A: To be completed by donor FIRST/LAST NAME NAME OF ORGANIZATION RECEIVING GIFT PHILIP MORRIS USA PERSONNEL NUMBER ORGANIZATION’S CITY/STATE/ZIP CODE Please include any leading zeros. Your Philip Morris USA Personnel Number can be found by accessing My Info/My Staff through the Human Resources section on Philip Morris USA's intranet or on the stub of your payroll check in the box marked Employee ID. $ , .00 HOME ADDRESS CHECK IF NEW ADDRESS AMOUNT OF GIFT (MINIMUM $25) CITY/STATE/ZIP CODE EXACT DATE OF GIFT (MONTH/DAY/YEAR) CHECK CREDIT SECURITIES DEPARTMENT NAME # SHARES BUSINESS E-MAIL ADDRESS NAME OF COMPANY STOCK PERSONAL E-MAIL ADDRESS DAYTIME PHONE NUMBER EMPLOYEE CERTIFICATION: I am currently an eligible employee of Philip Morris USA. The information submitted is correct and my gift qualifies as a tax-deductible gift to a tax-exempt public charity recognized by the Internal Revenue Service under Section 501(c)(3) of the Internal Revenue Code. My gift has been paid and is a current, personal contribution and is not a future pledge. This is an individual gift and not pooled with funds belonging to others. Neither I nor my family will derive any direct or indirect financial or material benefit from this gift. My gift does not represent payment for service. I understand that misuse of the Philip Morris USA Matching Gifts Program will result in permanent revocation of my matching gifts privileges and may lead to other disciplinary actions, including termination. I have read and understand the Philip Morris USA Matching Gifts Program Guidelines, and I submit this request in accordance with them.
    [Show full text]
  • National Register of Historic Places Registration Form
    NPS Form 10-900 OMB No. 10024·0018 (Oct. 1990) United States Department of the Interior National Park Service National Register of Historic Places Registration Form This form is for use in nominating or requesting determinations for individual properties and districts. See instructions in How to Complete the National Register of Historic Places Registration Form (National Register Bulletin 16A). Complete each item by marking "x" in the appropriate box or by entering the information requested. If an item does not apply to the property being documented, enter "N/A" for "not applicable." For functions, architectural classification, materials, and areas of significance, enter only categories and subcategories from the instructions. Place additional entries and narrative items on continuation sheets (NPS Form 10-900a). Use a typewriter, word processor, or computer, to complete all items. 1. Name of Property historic name ___B_r_i:=gc_h_t_Le_a_f_Hi_· s_t_o_r_J._· c_D_J._· s_t_r_J._· c_t ___________________ _ other names/site number---------------------------------- 2. Location bounded roughly by w. Peabody St., N. & S. Duke St., Minerva Ave., street & number _N~&"'l"-·1 _,RR"?''---"C"'o"'rp=o r"'a"'t"'J."''o"'n"--"S'-'t,_,._,,---"'L"'i g"'g"'e"'t"'t"'-'S'-'t'-''-''---"'r!""o"'r r=.l.=:.s"'-'S"-'t'-'''-''~---'N it! not for publication li'est Loop city or town ------"'Dur"""'h"'am~-----------------------N=AD vicinity state North Carolina code NC county __;Dur=JJh'<!amm~----- code 063 zip code 27702 3. State/Federal Agency Certification As the designated authority under the National Historic Preservation Act, as amended, I hereby certify that this Q9 nomination D request for determination of eligibility meets the documentation standards for registering properties in the National Register of lj!ptoric Places and meets the procedural and professional requirements set forth in 36 CFA Part 60.
    [Show full text]
  • Addiction at Any Cost: Philip Morris International Uncovered Chapter One Chapter
    ADDICTION AT ANY COST Philip Morris International Uncovered ADDICTION AT ANY COST Philip Morris International Uncovered Acknowledgements & Contributions We acknowledge the support of Bloomberg Philanthropies Stopping Tobacco Organizations and Products project funding (www.bloomberg.org). The following researchers from the University of Bath authored each of the report chapters: Chapter 1 – Mateusz Zatonski, Silvy Peeters, Anna Gilmore Chapter 2 – Britta K Matthes, Rosemary Hiscock, Karen Evans-Reeves Chapter 3 – Karen Evans-Reeves, Kathrin Lauber (contributions from Janet Hoek, Lindsay Robertson and Debby Sy) Chapter 4 – Tess Legg with input from Anna Gilmore Chapter 5 – Tess Legg with input from Anna Gilmore Karen Evans-Reeves acted as lead author and editor of the report. Anna Gilmore provided substantive edits for each chapter. The authors would like to thank STOP Partners – the Global Center for Good Governance on Tobacco Control, Vital Strategies & The International Union Against Tuberculosis and Lung Disease (The Union) – for feedback on a draft of the report, Union subgrantees for providing information on combustible cigarette marketing and Lindsay Robertson for editorial assistance. Vital Strategies were responsible for the production design and publishing of the report and a corresponding website. Contents Executive Summary Glossary of Terms 10 Chapter 1 The Tobacco Industry and Harm Reduction: A History of Deception 22 Chapter 2 Global Tobacco and Next Generation Product Market, and Philip Morris International 30 Chapter 3 Philip
    [Show full text]